** Shares of the medical technology company TCMD.O fall
17.99% to $35.49 in late morning trade
** Stock is on track for its worst daily pct loss on record
** Posts Q2 loss vs year-ago profit; total revenue declines
22% to $35.1 mln during the quarter urn:newsml:reuters.com:*:nGNX6xNqTN
** Co says Q2 revenue was hurt by limited access to co's
clinician customers and their patients
** During the quarter, co continued to see healthcare
facilities, clinics reducing patient consultations or closing
temporarily due to COVID-19
** "As we look ahead to the remainder of 2020, we expect the
COVID-19 pandemic to continue to impact our financial and
operational results" - CEO
** TCMD makes medical devices for at-home treatment of
chronic diseases
** Stock is down 47.1% this year
(Reporting by Sanjana Shivdas in Bengaluru)
((SanjanaSitara.Shivdas@thomsonreuters.com; within U.S. +1 646
223 8780, outside U.S. +91 80 6749 1642; Twitter:
@SanjanaShivdas;))